Authors:
Dunbar, GL
Shear, DA
Dong, J
Haik-Creguer, KL
Citation: Gl. Dunbar et al., Cognitive and motor deficits produced by acute and chronic administration of 3-nitropropionic acid in rats, CONT NEUROS, 2000, pp. 73-92
Citation: Kj. Page et al., The 3-nitropropionic acid model of Huntington's disease - Do alterations in the expression of metabolic mRNAs predict the development of striatal pathology?, CONT NEUROS, 2000, pp. 141-156
Authors:
Kumazaki, M
Ungsuparkorn, C
Deshpande, SB
Fukuda, A
Nishino, H
Citation: M. Kumazaki et al., Mechanisms of action of 3-nitropropionic acid - Dopamine overflow and vulnerability of the lateral striatal artery, CONT NEUROS, 2000, pp. 157-165
Citation: Sp. Gabbita et al., Effects of brain mitochondrial metabolism, aging, and caloric restriction on membrane lipids and proteins - An electron paramagnetic resonance investigation, CONT NEUROS, 2000, pp. 177-200
Citation: Zk. Binienda et Ac. Scallet, Neuroprotective effect of perinatal hypoxia against 3-nitropropionic acid neurotoxicity, CONT NEUROS, 2000, pp. 265-274
Authors:
Borlongan, CV
Stahl, CE
Freeman, TB
Hauser, RA
Sanberg, PR
Citation: Cv. Borlongan et al., Neural transplantation and Huntington's disease - What can we learn from the 3-nitropropionic acid model?, CONT NEUROS, 2000, pp. 275-291
Citation: Mbh. Youdim et al., Neuroprotective strategies in Parkinson's disease and Huntington's chorea - MPTP- and 3-NPA-induced neurodegeneration as models, CONT NEUROS, 2000, pp. 293-309